Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  25 results for ""THERAPEUTIC use of monoclonal antibodies""

Your Filters

Content Provider : Complementary Index Subject : lupus nephritis Subject : anti-cd20 Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Kidney Outcomes and Preservation of Kidney Function With Obinutuzumab in Patients With Lupus Nephritis: A Post Hoc Analysis of the NOBILITY Trial.

Subjects: KIDNEY physiology; THERAPEUTIC use of monoclonal antibodies; STATISTICS

  • Source: Arthritis & Rheumatology; Feb2024, Vol. 76 Issue 2, p247-254, 8p

Record details

Read More Add to Saved list
×
Academic Journal

An update on managing patients with multiple sclerosis in primary care.

Subjects: MULTIPLE sclerosis diagnosis; MULTIPLE sclerosis prevention; THERAPEUTIC use of monoclonal antibodies

  • Source: JAAPA: Journal of the American Academy of Physician Assistants (Lippincott Williams & Wilkins); Feb2024, Vol. 37 Issue 2, p22-29, 8p

Record details

Read More Add to Saved list
×
Academic Journal

Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti‐CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Trial.

Subjects: THERAPEUTIC use of monoclonal antibodies; GLUCOCORTICOIDS; DRUG efficacy

  • Source: Arthritis & Rheumatology; Nov2023, Vol. 75 Issue 11, p1983-1993, 11p

Record details

Read More Add to Saved list
×
Academic Journal

A typical clinical manifestation of atypical underlying diagnosis: Answers.

Subjects: THERAPEUTIC use of monoclonal antibodies; IMMUNOCHEMISTRY; LUPUS nephritis

  • Source: Pediatric Nephrology; Nov2023, Vol. 38 Issue 11, p3615-3617, 3p, 2 Color Photographs

Record details

Read More Add to Saved list
×
Academic Journal

The use of combination monoclonal antibody therapies in lupus—where are we now?

Subjects: THERAPEUTIC use of monoclonal antibodies; DRUG efficacy; RITUXIMAB

  • Source: Rheumatology; May2023, Vol. 62 Issue 5, p1724-1729, 6p

Record details

Read More Add to Saved list
×
Academic Journal

Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors.

Subjects: CHRONIC leukemia; LYMPHOCYTIC leukemia; PROGNOSIS

  • Source: BMC Cancer; 11/25/2022, Vol. 22 Issue 1, p1-17, 17p

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study.

Subjects: DRUG therapy for rheumatism; THERAPEUTIC use of monoclonal antibodies; RITUXIMAB

  • Source: Clinical Infectious Diseases; Jul2022, Vol. 75 Issue 1, pe1037-e1045, 9p

Record details

Read More Add to Saved list
×
Academic Journal

Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis.

Subjects: THERAPEUTIC use of monoclonal antibodies; GLUCOCORTICOIDS; RESEARCH

  • Source: Annals of the Rheumatic Diseases; Apr2022, Vol. 81 Issue 4, p496-506, 66p

Record details

Read More Add to Saved list
×
Academic Journal

B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial.

Subjects: THERAPEUTIC use of monoclonal antibodies; GLOMERULAR filtration rate; RESEARCH

  • Source: Annals of the Rheumatic Diseases; Jan2022, Vol. 81 Issue 1, p100-107, 8p

Record details

Read More Add to Saved list
×
Academic Journal

From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?

Subjects: THERAPEUTIC use of monoclonal antibodies; RESEARCH; LUPUS nephritis

  • Source: Annals of the Rheumatic Diseases; Jan2022, Vol. 81 Issue 1, p15-19, 5p

Record details

Read More Add to Saved list
×
  • 1-10 of  25 results for ""THERAPEUTIC use of monoclonal antibodies""